Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$332 Mln
P/E Ratio
20.04
P/B Ratio
1.53
Industry P/E
--
Debt to Equity
0.09
ROE
0.08 %
ROCE
7.07 %
Div. Yield
0 %
Book Value
8.85
EPS
0.69
CFO
$69.60 Mln
EBITDA
$67.56 Mln
Net Profit
$28.01 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Tactile Systems Technology (TCMD)
| -16.23 | 7.98 | -17.34 | -1.51 | -7.33 | -22.94 | -- |
|
BSE Sensex
| 1.99 | 3.77 | 4.29 | 8.22 | 11.74 | 20.16 | 11.15 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Tactile Systems Technology (TCMD)
| 19.61 | 24.56 | -39.67 | -57.65 | -33.43 | 48.21 | 56.79 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.50 | 10,541.60 | 14.73 | 12.69 | |
| 73.07 | 9,636.16 | 93.23 | 2.52 | |
| 162.63 | 8,533.78 | -- | -25.23 | |
| 298.25 | 10,783.83 | 774.36 | 1.2 |
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of... lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. Address: 3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416 Read more
President, CEO & Director
Mr. Daniel L. Reuvers
President, CEO & Director
Mr. Daniel L. Reuvers
Headquarters
Minneapolis, MN
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Tactile Systems Technology Inc (TCMD) stood at $ 298 Mln as on 31-Dec-24
The share price of Tactile Systems Technology Inc (TCMD) is $14.35 (NASDAQ) as of 24-Apr-2025 16:01 EDT. Tactile Systems Technology Inc (TCMD) has given a return of -7.33% in the last 3 years.
Tactile Systems Technology Inc (TCMD) has a market capitalisation of $ 332 Mln as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Tactile Systems Technology Inc (TCMD) is 20.04 times as on 24-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Tactile Systems Technology Inc (TCMD) and enter the required number of quantities and click on buy to purchase the shares of Tactile Systems Technology Inc (TCMD).
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. Address: 3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416
The CEO & director of Mr. Daniel L. Reuvers. is Tactile Systems Technology Inc (TCMD), and CFO & Sr. VP is Mr. Daniel L. Reuvers.
There is no promoter pledging in Tactile Systems Technology Inc (TCMD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Tactile Systems Technology Inc. (TCMD) | Ratios |
|---|---|
|
Return on equity(%)
|
8.27
|
|
Operating margin(%)
|
8.73
|
|
Net Margin(%)
|
5.79
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Tactile Systems Technology Inc (TCMD) was $0 Mln.
$0.32
(
